Cargando…

Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy

BACKGROUND: Dysthyroid optic neuropathy (DON) is one of the most serious vision-threatening complications of thyroid eye disease (TED); however, accurate and established diagnostic tools for DON are yet lacking. The present study was aimed at identifying new diagnostic factors for the accurate diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Zhihong, Chen, Lu, Tan, Jia, Wang, Sha, Liu, Dan, Wang, Jinwei, Jiang, Chengzhi, Yang, Jie, Xu, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154283/
https://www.ncbi.nlm.nih.gov/pubmed/34113406
http://dx.doi.org/10.1155/2021/9964232
_version_ 1783698978981806080
author Deng, Zhihong
Chen, Lu
Tan, Jia
Wang, Sha
Liu, Dan
Wang, Jinwei
Jiang, Chengzhi
Yang, Jie
Xu, Bei
author_facet Deng, Zhihong
Chen, Lu
Tan, Jia
Wang, Sha
Liu, Dan
Wang, Jinwei
Jiang, Chengzhi
Yang, Jie
Xu, Bei
author_sort Deng, Zhihong
collection PubMed
description BACKGROUND: Dysthyroid optic neuropathy (DON) is one of the most serious vision-threatening complications of thyroid eye disease (TED); however, accurate and established diagnostic tools for DON are yet lacking. The present study was aimed at identifying new diagnostic factors for the accurate diagnosis of DON. METHODS: This retrospective cross-sectional study included 25 TED patients (50 eyes) with enlarged extraocular muscles, no previous anti-inflammatory therapy, and the absence of other vision-affecting diseases between May 2017 and August 2019. Baseline data, such as gender, age, ophthalmological history, thyroid disease and management, TED history including clinical features, management, and long-term results, ophthalmological examinations, serology examinations, and single-photon emission computed tomography/computed tomography (SPECT/CT) results, were extracted. The diagnostic criteria were as follows: (1) best-corrected visual acuity (BCVA) loss coexisting with either of the following—increased latency or reduction of amplitude on visual evoked potential (VEP), impaired color vision, visual field defects, contrast sensitivity impairment, and optic disk swelling—and (2) Barrett′s index ≥ 60% in CT. Univariate and multivariate logistic regression analyses assessed the differences in age, gender, eyes, medical history, clinical activity, thyroid hormone and antibodies, uptake ratio (UR) of extraocular muscles in SPECT/CT, and volumetric orbital apex crowding index (VACI) using the generalized estimation equation. Consequently, the receiver operating characteristic curve (ROC) of the significant factors was constructed. RESULTS: Univariate analysis revealed significant differences in the clinical activity, free triiodothyronine (FT3), free thyroxine (FT4), thyrotrophin receptor antibody (TRAb) levels, the UR of superior and medial rectus, and VACI between DON and TED (without DON) groups. Multivariate regression analysis revealed that TRAb and VACI were significantly different. ROC analysis showed that the univariate models of TRAb or VACI and the multivariate model were effective indicators of DON, while the multivariate model had the highest area under the ROC curve. CONCLUSION: A combination of TRAb and VACI is an effective indicator for DON.
format Online
Article
Text
id pubmed-8154283
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-81542832021-06-09 Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy Deng, Zhihong Chen, Lu Tan, Jia Wang, Sha Liu, Dan Wang, Jinwei Jiang, Chengzhi Yang, Jie Xu, Bei Dis Markers Research Article BACKGROUND: Dysthyroid optic neuropathy (DON) is one of the most serious vision-threatening complications of thyroid eye disease (TED); however, accurate and established diagnostic tools for DON are yet lacking. The present study was aimed at identifying new diagnostic factors for the accurate diagnosis of DON. METHODS: This retrospective cross-sectional study included 25 TED patients (50 eyes) with enlarged extraocular muscles, no previous anti-inflammatory therapy, and the absence of other vision-affecting diseases between May 2017 and August 2019. Baseline data, such as gender, age, ophthalmological history, thyroid disease and management, TED history including clinical features, management, and long-term results, ophthalmological examinations, serology examinations, and single-photon emission computed tomography/computed tomography (SPECT/CT) results, were extracted. The diagnostic criteria were as follows: (1) best-corrected visual acuity (BCVA) loss coexisting with either of the following—increased latency or reduction of amplitude on visual evoked potential (VEP), impaired color vision, visual field defects, contrast sensitivity impairment, and optic disk swelling—and (2) Barrett′s index ≥ 60% in CT. Univariate and multivariate logistic regression analyses assessed the differences in age, gender, eyes, medical history, clinical activity, thyroid hormone and antibodies, uptake ratio (UR) of extraocular muscles in SPECT/CT, and volumetric orbital apex crowding index (VACI) using the generalized estimation equation. Consequently, the receiver operating characteristic curve (ROC) of the significant factors was constructed. RESULTS: Univariate analysis revealed significant differences in the clinical activity, free triiodothyronine (FT3), free thyroxine (FT4), thyrotrophin receptor antibody (TRAb) levels, the UR of superior and medial rectus, and VACI between DON and TED (without DON) groups. Multivariate regression analysis revealed that TRAb and VACI were significantly different. ROC analysis showed that the univariate models of TRAb or VACI and the multivariate model were effective indicators of DON, while the multivariate model had the highest area under the ROC curve. CONCLUSION: A combination of TRAb and VACI is an effective indicator for DON. Hindawi 2021-05-18 /pmc/articles/PMC8154283/ /pubmed/34113406 http://dx.doi.org/10.1155/2021/9964232 Text en Copyright © 2021 Zhihong Deng et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Deng, Zhihong
Chen, Lu
Tan, Jia
Wang, Sha
Liu, Dan
Wang, Jinwei
Jiang, Chengzhi
Yang, Jie
Xu, Bei
Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_full Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_fullStr Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_full_unstemmed Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_short Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_sort combination model of thyrotrophin receptor antibody and volumetric orbital apex crowding index as an indicator of dysthyroid optic neuropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154283/
https://www.ncbi.nlm.nih.gov/pubmed/34113406
http://dx.doi.org/10.1155/2021/9964232
work_keys_str_mv AT dengzhihong combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT chenlu combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT tanjia combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT wangsha combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT liudan combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT wangjinwei combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT jiangchengzhi combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT yangjie combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT xubei combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy